Gadd45α regulates p38-dependent dendritic cell cytokine production and Th1 differentiation

Journal of Immunology

Volumn 178, Issue 7, 2007, Pages 4153-4158

  Jirmanova, Ludmila ^a   Janković, Dragana ^b   Fornace Jr , Albert J ^c   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45ALPHA; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PARASITE ANTIGEN; PROTOZOAL PROTEIN; TYROSINE; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; GADD45A PROTEIN, MOUSE; NUCLEAR PROTEIN; SOLUBLE TACHYZOITE ANTIGEN, TOXOPLASMA GONDII;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TH1 CELL; TISSUE SPECIFICITY; TOXOPLASMA GONDII; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD40; ANTIGENS, PROTOZOAN; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL POLARITY; CYTOKINES; DENDRITIC CELLS; INTERLEUKIN-12; MICE; MICE, MUTANT STRAINS; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TH1 CELLS; TYROSINE;

EID: 33947658043     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.7.4153     Document Type: Article

References (38)

1. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1: 199-205.
2. Santana, M. A., and Y. Rosenstein. 2003. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J. Cell. Physiol. 195: 392-401.
3. - dendritic cells to prime Th1/ Th2 cells in vivo. J. Immunol. 167: 4345-4350.
4. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S. Su, L. A. Penix, R. J. Davis, and R. A. Flavell. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17: 2817-2829.
5. Yu, J. J., C. S. Tripp, and J. H. Russell. 2003. Regulation and phenotype of an innate Th1 cell: role of cytokines and the p38 kinase pathway. J. Immunol. 171: 6112-6118.
6. Zhang, J., K. V. Salojin, J. X. Gao, M. J. Cameron, I. Bergerot, and T. L. Delovitch. 1999. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162: 3819-3829.
7. Kim, J. M., J. M. White, A. S. Shaw, and B. P. Sleckman. 2005. MAPK p38α is dispensable for lymphocyte development and proliferation. J. Immunol. 174: 1239-1244.
8. Berenson, L. S., J. Yang, B. P. Sleckman, T. L. Murphy, and K. M. Murphy. 2006. Selective requirement of p38α MAPK in cytokine-dependent, but not antigen receptor-dependent, Th1 responses. J. Immunol. 176: 4616-4621.
9. Fornace, A. J., Jr., D. W. Nebert, M. C. Hollander, J. D Luethy, M. Papathanasiou, J. Fargnoli, and N. J. Holbrook. 1989. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9: 4196-4203.
10. Zhang, W., I. Bae, K. Krishnaraju, N. Azam, W. Fan, K. Smith, B. Hoffman, and D. A. Liebermann. 1999. CR6: A third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18: 4899-4907.
11. Lu, B., H. Yu, C. Chow, B. Li, W. Zheng, R. J. Davis, and R. A. Flavell. 2001. GADD45γ mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector Th1 cells. Immunity 14: 583-590.
12. Lu, B., A. F. Ferrandino, and R. A. Flavell. 2004. Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nat. Immunol. 5: 38-44.
13. Yang, J., H. Zhu, T. L. Murphy, W. Ouyang, and K. M. Murphy. 2001. IL-18-stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2: 157-164.
14. Takekawa, M., and H. Saito. 1998. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95: 521-530.
15. Salvador, J. M., P. R. Mittelstadt, T. Guszczynski, T. D. Copeland, H. Yamaguchi, E. Appella, A. J. Fornace, Jr., and J. D. Ashwell. 2005. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat. Immunol. 6: 390-395.
16. Salvador, J. M., M. C. Hollander, A. T. Nguyen, J. B. Kopp, L. Barisoni, J. K. Moore, J. D. Ashwell, and A. J. Fornace, Jr. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16: 499-508.
17. Salvador, J. M., P. R. Mittelstadt, G. I. Belova, A. J. Fornace, Jr., and J. D. Ashwell. 2005. The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway. Nat. Immunol. 6: 396-402.
18. Bulavin, D. V., O. Kovalsky, M. C. Hollander, and A. J. Fornace, Jr. 2003. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol. Cell. Biol. 23: 3859-3871.
19. Hildesheim, J., D. V. Bulavin, M. R. Anver, W. O. Alvord, M. C. Hollander, L. Vardanian, and A. J. Fornace, Jr. 2002. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62: 7305-7315.
20. Hollander, M. C., M. S. Sheikh, D. V. Bulavin, K. Lundgren, L. Augeri-Henmueller, R. Shehee, T. A. Molinaro, K. E. Kim, E. Tolosa, J. D. Ashwell, et al. 1999. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23: 176-184.
21. Grunvald, E., M. Chiaramonte, S. Hieny, M. Wysocka, O. Trinchieri, S. N. Vogel, R. T. Gazzinelli, and A. Sher. 1996. Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect. Immun. 64: 2010-2018.
22. Boros, D. L., and K. S. Warren. 1970. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132: 488-507.
23. Wange, R. L., R. Guitian, N. Isakov, J. D. Watts, R. Aebersold, and L. E. Samelson. 1995. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 270: 18730-18733.
24. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, and A. Sher. 2002. Cutting edge; MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168: 5997-6001.
25. Sher, A., C. Collazzo, C. Scanga, D. Jankovic, O. Yap, and J. Aliberti. 2003. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunol. Res. 27: 521-528.
26. Yarovinsky, F., D. Zhang, J. F. Andersen, O. L. Bannenberg, C. N. Serhan, M. S. Hayden, S. Hieny, F. S. Sutterwala, R. A. Flavell, S. Ghosh, and A. Sher. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629.
27. Pearce, E. J., C. M. Kane, J. Sun, J. J Taylor, A. S. McKee, and L. Cervi. 2004. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol. Rev. 201: 117-126.
28. Aliberti, J., D. Jankovic, and A. Sher. 2004. Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection. Immunol. Rev. 201: 26-34.
29. -/- setting. Immunity 16: 429-439.
30. Straw, A. D., A. S. MacDonald, E. Y. Denkers, and E. J. Pearce. 2003. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J. Immunol. 170: 727-734.
31. - murine dendritic cell subsets. J. Immunol. 172: 4826-4833.
32. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al. 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360: 225-231.
33. -/- mice. J. Immunol. 154: 1569-1576.
34. Cannons, J. L., Y. Choi, and T. H. Watts. 2000. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response. J. Immunol. 165: 6193-6204.
35. Miyaura, H., and M. Iwata. 2002. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168: 1087-1094.
36. Yap, G., M. Pesin, and A. Sher. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165: 628-631.
37. Reis e Sousa, C., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186: 1819-1829.
38. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153: 2533-2543.